Chenglai Xia

5PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityCancer geneticsTraditional Chinese medicine and treatmentsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 27, 2026
AZD4635 Targets cAMP/CREB Axis to Salvage PARPi-Induced Immune Evasion and Enhance Antitumor Efficacy in Ovarian Cancer.

Botao Pan, Xiujuan Yang, Xuanji Wang

|Apr 17, 2025
Maslinic Acid Ameliorates DSS-Induced Experimental Colitis by Suppressing Th Cell-Mediated Inflammation via AICD Induction.

Dan Li, Zhan-Dong Ye, Mu-Xia Li

|Mar 02, 2023
Human microbiomes in cancer development and therapy.

Chenglai Xia, Jiyan Su, Can Liu

|Jul 30, 2021
Pharmacological Mechanisms Underlying the Hepatoprotective Effects of <i>Ecliptae herba</i> on Hepatocellular Carcinoma.

Botao Pan, Wenxiu Pan, Zheng Lu

|Jul 08, 2020
Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression.

Chenglai Xia, Chang Liu, Zhihong He

Pageof 1

Frequent Collaborators

1 joint publications

Dan Li

1 joint publications

Botao Pan

1 joint publications

Wenxiu Pan

1 joint publications

Zheng Lu